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We have cloned a mouse cDNA that encodes ~36, a 
novel subunit of the CDK-activating kinase (CAK). p36 
contains a C3HC4 zinc-binding domain or RING finger 
and is associated both with a TFIIH-bound form of CAK 
and with a free trimeric form. p36 promotes the as- 
sembly of CDK7 and cyclin H in vitro, stabilizing the 
transient CDK7-cyclin H complex. Stabilization and 
activation of CAK by p36 is independent of the phos- 
phorylation state of T170, the conserved activating 
residue of CDK7. Assembly of active CDK7-cyclin H 
dimers can also occur through an alternative p36- 
independent pathway that requires phosphorylation 
of T170 by a CAK-activating kinase, or CAKAK. Thus, 
CDK7-cyclin H complex formation can be achieved by 
multiple mechanisms. 
Introduction 
The cyclin-dependent kinases (CDKs) are regulatory en- 
zymes that initiate and coordinate events of the eukaryotic 
cell cycle (for reviews see Norbury and Nurse, 1992; Mor- 
gan, 1995). Phosphorylation of a conserved threonine resi- 
due in the catalytic subunit is required for activation of all 
known CDKs. The enzyme responsible for this modifica- 
tion, the CDK-activating kinase (CAK), has recently been 
identified and characterized in several species. Molecular 
cloning of two CAK subunits revealed that CAK is itself a 
cyclin-dependent kinase composed of a catalytic subunit, 
CDK7, and a positive regulatory subunit, cyclin H (Fesquet 
et al., 1993; Poon et al., 1993; Solomon et al., 1993; Fisher 
and Morgan, 1994; Makela et al., 1994). The reconstituted 
enzyme phosphorylates and activates complexes of CDCP 
(CDKl) and CDK2 with various cyclins (Fisher and Mor- 
gan, 1994; Makela et al., 1994), as well as CDK4-cyclin 
D2 complexes (Matsuoka et al., 1994). The activation of 
one CDK by another suggested the existence of a CDK 
cascade effecting cell cycle transitions. Consistent with 
this model, CDK7 itself required an activating threonine 
residue (T170 in human CDK7) for reconstitution of full 
enzymatic activity in vitro (Fisher and Morgan, 1994; 
Labbe et al., 1994; Poon et al., 1994) perhaps reflecting 
a dependence of CDK7-cyclin H binding on T170 phos- 
phorylation (Makela et al., 1994). 
Analyses of CAK activity and CDK7 protein (Brown et 
al., 1994; Matsuoka et al., 1994; Poon et al., 1994; Tassan 
et al., 1994) and of cyclin H protein (H. M. C. and D. 0. M., 
unpublished data) revealed essentially constant levels 
throughout the cell cycle and led to the conclusion that 
activating phosphorylation by CAK may not be rate-limiting 
in vivo, at least under the conditions (and for the CDK 
targets) tested (Matsuoka et al., 1994; Tassan et al., 1994). 
On the other hand, the demonstration that CAK is an es- 
sential component of the transcription-DNA repair factor 
TFIIH (Roy et al., 1994; Serizawa et al., 1995; Shiekhattar 
et al., 1995) makes such measurements more difficult to 
interpret. CAK probably exists in both TFIIH-bound and 
unbound forms (Roy et al., 1994; Shiekhattar et al., 1995) 
that may be regulated differently; entry into or exit from 
the TFIIH complex could be a regulatory mechanism in 
itself. 
In this report, we show that CAK purified from mouse 
tissue culture cells contains three polypeptides in appar- 
ently equimolar amounts: CDK7, cyclin H, and a novel 
polypeptide of - 36 kDa (~36). CAK purified by immunoaf- 
finity from human cells with antibodies against CDK7 (Tas- 
san et al., 1994), or against cyclin H, shows a similar three- 
subunit composition. We have cloned a mouse cDNA 
encoding ~36; the sequence contains a C3HC4 zinc- 
binding domain near its amino terminus and a central re- 
gion with the potential to form a coiled coil. p36 is present 
in both a soluble - 175 kDa form of CAK and in a - 650 
kDa TFIIH-associated form. Purified p36 promotes stable 
binding of CDK7 and cyclin H and circumvents the need 
for T170 phosphorylation; CDK7-cyclin H-p36 complexes 
bearing a mutation of T170 to alanine (T170A) are fully 
active. Conversely, phosphorylation of T170 obviates the 
requirement for p36 both in vivo and in vitro, allowing as- 
sembly of active CDK7-cyclin H binary complexes. Thus, 
CAK may be assembled and activated through two poten- 
tially independent pathways, depending on the availability 
and activity of the assembly factor ~36, an activating ki- 
nase, or both. 
Results 
Purification of Three-Subunit CAK and 
Identification of a Novel Subunit 
We previously described the purification of CAK from 
mammalian cell extracts by conventional chromatogra- 
phies (Fisher and Morgan, 1994). In some CAK prepara- 
tions from HeLa cells, the final enzyme fraction contained 
only two major polypeptides, CDK7 and cyclin H. In con- 
trast, purification of CAK from mouse 3T3 cell extracts by 
a similar scheme consistently resulted in the copurification 
with CAK activity (Figure 1A) of three polypeptides of ap- 
parentlyequal abundance (Figure 1 B). In addition toCDK7 
and cyclin H, the purified enzyme contained a third poly- 
peptide with an apparent molecularweight of 36 kDa(p36). 
In preparative polyacrylamide gels, cyclin H and p36 
comigrated (see Figure 2C of Fisher and Morgan, 1994). 
We therefore subjected a mixture of the two polypeptides 
to tryptic peptide sequencing, which yielded four peptides 
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Figure 1. Purification of Murine CAK 
(A) Activation of CDKP-cyclin A by murine CAK. Fractions eluted from 
HiTrap Cl (1 ~1 or l/1000 of total) were incubated with CDK2-cyclin 
A immunoprecipitates, which were washed and tested for the ability 
to phosphorylate histone Hl (indicated at left). 
(6) Polypeptidecompositionof purified mouseCAK. HiTrapQfractions 
(10 ~1 or 11100 of total) were electrophoresed in a 10% polyacrylamide 
gel, and polypeptides were visualized by silver staining. The positions 
of molecular weight markers are shown at left. Also indicated at left 
are the positions of the three CAK subunits: CDK7, cyclin H, and ~36. 
polymerase chain reaction (PCR) to amplify a 451 bp frag- 
ment, which we in turn used to isolate the full-length ~36 
cDNA from a mouse library. The - 1.4 kb cDNA contains 
an open reading frame of 309 amino acids that potentially 
encodes a polypeptide with a predicted molecular weight 
of 35.8 kDa (Figure 2A). All four p36 peptides are present 
in the open reading frame. 
CAK p36 Is a Novel RING Finger Protein 
A search of the GenBank database revealed no extensive 
homologies with known proteins. However, p36 contains 
a recently defined structural motif, the C3HC4 zinc-binding 
domain or RING finger (reviewed by Freemont, 1993). An 
alignment of p36 with several representative RING do- 
mains (Figure 28) revealed perfect conservation of the 
metal-ligating cysteine and histidine residues. Also con- 
served is the location of the RING finger near the amino 
terminus of ~36. No other obvious structural motifs were 
found, although a central region of the protein is predicted 
to form a coiled coil (Figure 2A; Lupas et al., 1991) and 
shows limited homologies with other coiled-coil proteins. 
p36 Is a Component of CAK-TFIIH Complexes 
CDK7 and cyclin H are associated with the RNA polymer- 
ase II general transcription factor TFIIH (Roy et al., 1994; 
Serizawa et al., 1995; Shiekhattar et al., 1995). To deter- 
mine whether p36 was also associated with TFIIH, we frac- 
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Figure 2. ~36, a Novel CAK Subunit with a RING Finger Domain 
(A) cDNA sequence of CAK ~36. The complete cDNA sequence of 
murine ~36 is shown with the 309 amino acid open reading frame it 
encodes. The four tryptic peptides are indicated by broken underlines. 
The sequence of peptide 1 actually began with an aspartate residue, 
instead of the glutamic acid predicted by the cDNA sequence. The 
metal-coordinating residues of the CSHCl domain are denoted by bold 
typeface and asterisks. A region predicted to formed coiled-coil struc- 
ture (amino acids 90-180) is indicated by the double underline. 
(B) Alignment of the p36 RING finger with other family members. The 
conserved metal-ligating residues are in bold typeface. Proteins listed 
are as follows: SS-A/Ro (Chan et al., 1991) RPT-1 (Patarca et al., 
1988) XNF7 (Reddy et al., 1991) PML (Goddard et al., 1991), EHVl 
(Barlow et al., 1994) RING1 (Lovering et al., 1993) and BMll (Haupt 
et al., 1991; van Lohuizen et al., 1991). 
tionated hypotonic lysates of HeLa cells into soluble 
(S-100) and high salt (0.42 M  KCI) extracted nuclear frac- 
tions (Dignam et al., 1983), which were then subjected to 
gel exclusion chromatography. Fractions were analyzed 
by immunoblotting for the presence of CDK7, cyclin H, 
~36, and the TFIIH polypeptide ~62. Fractionation of the 
nuclear extract (Figure 3A) resulted in a major peak of the 
three CAK subunits at - 650 kDa (fractions 31-33), which 
coincided exactly with the peak of ~62. A second, minor 
peak of CDK7, cyclin H, and p36 immunoreactivity ap- 
peared at - 175-200 kDa (fractions 41-45), with no corre- 
sponding peak of ~62. We also consistently observed a 
trail of both CDK7 and cyclin H, apparently unassociated 
with ~36, at lower apparent molecular weights (fractions 
47-49). In the S-100, the situation was reversed (Figure 
3B). The three CAK components were predominantly in 
the lower molecular weight form (fractions 41-45). A small 
amount of the TFIIH component, ~62, copurified with a 
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Figure 3. Two Distinct CAK Complexes Contain p36 
(A) CAKextracted from nuclei is in a -650 kDaTFIIH-containing com- 
plex. HeLa nuclear extract was subjected to gel filtration chromatogra- 
phy on Superdex 200. Alternate fractions were analyzed by immu- 
noblotting with antibodies to the TFIIH subunit ~62, CDK7, cyclin H, 
and ~36. Positions of molecular weight standard proteins thyroglobulin 
(669 kDa), ferritin (440 kDa), aldolase (158 kDa), BSA (67 kDa), oval- 
bumin (45 kDa), and cytochrome C (12 kDa) are indicated at top. 
(B) Soluble CAK is in a - 175 kDa complex. HeLa S-l 00 was analyzed 
by gel filtration, exactly as in (A). Each run of the sizing column repre- 
sented approximately equal numbers of cells. 
(C) Subunit composition of distinct CAK complexes. We subjected the 
- 650 kDa CAK-containing complex derived from the nuclear extract 
(lanes 2 and 5) and the - 175 kDa complex isolated from the S-100 
(lanes 3 and 6) to anti-cyclin H immunoaffinity chromatography. Alka- 
line eluates from the antibody column were analyzed by immunoblot- 
ting (lanes l-3) with antibodies against ~62, CDK7, cyclin H, and ~36, 
and by silver staining (lanes 4-6). A fraction of HeLa CAK purified 
through the HiTrap Q step (Fisher and Morgan, 1994) was analyzed 
in lanes 1 and 4. 
(D) p36 is a component of TFIIH. The - 650 kDa CAK-containing com- 
plex wassubjected toanti-p36immunoaffinitychromatography. Immu- 
noblotting with antibodies against p62 and p36 revealed partial deple- 
tion of both proteins (compare load [lane l] with flowthrough [lane 21). 
Neither protein was recovered by washing the column with HBS plus 
0.1% Triton X-100 (lane 3). Both proteins were recovered by pH 11.5 
elution (lanes 4 and 5). 
minor peak of the three CAK polypeptides, again at - 650 
kDa (fractions 31-33). The two major CAK-containing 
complexes appeared to be nearly equally abundant, on 
the basis of comparisons of the immunoblots. CDK7 has 
been shown to be predominantly nuclear in vivo (Tassan 
et al., 1994); the smaller form of the enzyme presumably 
represented a soluble intranuclear pool that diffused out 
of nuclei during hypotonic lysis. 
To compare the subunit compositions of the two CAK- 
containing complexes, we subjected both fractions to anti- 
cyclin H immunoaffinity chromatography. Both forms 
bound to the antibody column, as measured by depletion 
of cyclin H in the flowthrough, although depletion was in- 
complete for the nuclear extract-derived material (data 
not shown). In both cases, alkaline elution resulted in re- 
covery of CDK7, cyclin H, and p36 immunoreactivity (Fig- 
ure 3C, lanes 2 and 3). Upon chromatography of the high 
molecular weight fraction, the TFIIH subunit p62 was also 
retained and eluted with the CAK components (lane 2) 
confirming that CAK in the nuclear extract was associated 
with TFIIH. In contrast, p62 was absent from the eluate 
of the column loaded with - 175 kDa CAK (lane 3) and 
from a partially purified CAK fraction derived from HeLa 
S-100 by conventional chromatographies (lane 1; Fisher 
and Morgan, 1994). In addition, two other TFIIH compo- 
nents, ERCC2 and ERCCS, both copurified with nuclear 
extract-derived CAK, but not with CAK from the soluble 
S-l 00 (data not shown). Moreover, analysis by SDS-poly- 
acrylamide gel electrophoresis (SDS-PAGE) and silver 
staining of the anti-cyclin H-bound fraction derived from 
the S-100 revealed the three major CAK polypeptides, 
CDK7, cyclin H, and ~36, in apparent 1 :l :l stoichiometry 
(Figure 3C, lane 6). Similar analysis of the anti-cyclin H 
eluate derived from nuclear extract revealed a similar pat- 
tern, but with several (- 10) additional bands, possibly 
representing the other TFIIH subunits (Figure 3C, lane 5). 
The presence of p36 in both complexes suggested that 
the basic functional unit of CAK, whether free or com- 
plexed in TFIIH, is a trimer comprising CDK7, cyclin H, 
and ~36. Direct evidence for association between p36 and 
TFIIH was obtained by subjecting the -650 kDa CAK- 
TFIIH complex to anti-p36 immunoaffinity chromatogra- 
phy (Figure 3D). Both p36 and p62 were retained on the 
antibody column and eluted with high pH (lanes 4 and 5), 
as were CDK7, cyclin H, ERCC2, and ERCCB (data not 
shown). A control column lacking antibody did not bind 
any of the CAK or TFIIH subunits (data not shown). 
Reconstitution of Three-Subunit CAK In Vitro 
To study the novel CAK-associated polypeptide and its 
interactions with the two previously identified subunits, 
CDK7 and cyclin H, we constructed baculoviruses encod- 
ing p36 with either an amino-terminal hexahistidine tag 
(p36-His) or a carboxy-terminal hemagglutinin epitope tag 
(p36-HA), as well as the untagged protein. All three pro- 
teins were expressed in infected SF9 cells, and the un- 
tagged protein migrated in SDS-PAGE near the position 
of the authentic p36 in highly purified CAK fractions (data 
not shown). 
When a lysate containing p36-HA was incubated with 
pure recombinant CDK7 and cyclin H, active CAK could be 
immunoprecipitated with the monoclonal antibody 12CA5, 
which recognizes the HA epitope tag (Figure 4A, lane 4). 
No active kinase was recovered when any of the compo- 
nents was omitted (lanes l-3), or when an excess of com- 




Figure 4. p36 Facilitates CDK7-Cyclin H 
Binding 
CDK7 - + - + + 
cc ~cDK7 (A) Functional CAK reconstituted with CDK7, 
CycH - -+++ 
CycH+--- ---c- - cyclin H, and ~36. Pure CDK7 (500 ng), pure 
P36HA + + + + + 
cyclin H-His (500 ng), p36-HA (40 ng of total 
HADeDtlde - - - - + lysate protein containing - 1 ug of ~36) and 
CyCA* 
CDK7 * 
g -.. /- 
CDKP-. v-e 
1 2 3 4 5 6 7 8 9 10 11 12 13 14 HA peptide (5 Kg) were mixed as indicated 
above each lane (plus or minus) and immuno- 
C  precipitated with MAb 12CA5. Immunoprecipi- 
tates were washed and tested for the ability 
to phosphorylate CDK2 (indicated at left). Also 
phosphorylated are cyclin A and CDK7 (indi- 
cated at left). The open arrowheads indicate 
1 2 3 4 5 
phosphorylation products not dependent on 
p3sicyc H + CAK. 
CDKB+ uc^_(_ (6) p36 enhances CDK7-cyclin H binding. A 
* lysate containing - 1.25 ng of CDK7-HA was 
incubated with pure cyclin H (1.25 pg) without 
1 2 3 4 5 6 7 8 9 (lanes 1 and 8) or with increasing amounts of 
pure p36-His (75 ng, lane 2; 150 ng, lane 3; 
300 ng, lane 4; 600 ng, lane 5; 1.2 pg, lane 6; 
2.4 ng. lane 7). In a separate experiment, a lysate containing - 1 ng of p36-HA was incubated with pure CDK7 (1 ng, lanes 9 and 12) pure cyclin 
H (1 kg, lanes 10 and 13) or both (1 trg each, lanes 11 and 14). MAb 12CA5 immunoprecipitates were analyzed by immunoblotting with antibodies 
to cyclin H (lanes l-l 1, arrow at left) or to CDK7 (lanes 12-14, arrow at right). 
(C) p36 stimulates CAK activity. Duplicate immunoprecipitates were prepared as described in (B) (lanes l-7) and tested for the ability to phosphorylate 
CDK2-cyclin A. The position of CDK2 phosphorylated at T160 is indicated at left, as are the additional proteins labeled in the reaction: cyclin A, 
CDK7. and either p36-His or cvclin H (which comiarate). Controls were as follows: CDK7-HA without other proteins (lane 6) and with the addition 
of 1.2 ng of pure p36-His, but.without cyclin H (lane 9). 
three-subunit CAKcan be reconstituted in vitro with CDK7, 
cyclin H, and p36-HA. 
We attempted to purify CAK complexes both with and 
without ~36, in order to detect a role for the novel subunit 
in modulating enzymatic activity or substrate specificity. 
A mixture of three crude insect cell lysates (containing 
CDK7, p36-HA, and a histidine-tagged cyclin H) was sub- 
jected to cobalt affinity chromatography followed by Hi- 
Trap Q  anion exchange chromatography and Superose 
12 gel exclusion chromatography. Precise copurification 
of all three subunits at the last step indicated formation 
cf a stable complex, which migrated at a position consis- 
tent with a globular protein of - 175-200 kDa, coincident 
with the major peak of soluble CAK from HeLa cells (data 
not shown). In contrast, no two-subunit complex could be 
recovered by the same purification scheme starting with 
a mixture of lysates containing CDK7 and cyclin H-His 
(data not shown). 
p36 Is a CAK Assembly Factor 
To investigate further the effect of p36 on CDK7-cyclin H 
complex formation, we measured the amounts of cyclin 
H that coimmunoprecipitated with HA-tagged CDK7 both 
in the absence (Figure 46, lanes 1 and 6) or presence (in 
increasing amounts, lanes 2-7) of pure p36-His. The 
novel CAK subunit enhanced CDK7-cyclin H binding ap- 
proximately 5-fold. Duplicate immunoprecipitates were 
assayed for CAK activity, measured as the ability to phos- 
phorylate CDK2 (Figure 4C). The enhancement of CDK7- 
cyclin H binding by p36-His correlated with a 5 to lo-fold 
stimulation of enzymatic activity; stimulation of CAK activ- 
ity was saturated at a p36-His:CDK7 ratio of - 2:l (data 
not shown). We detected minimal binary complex forma- 
tion between p36-HA and cyclin H in the absence of CDK7 
(Figure 4B, lane IO), and between p36-HA and CDK7 in 
the absence of cyclin H (lane 12). When all three compo- 
nents were present, coprecipitation of both cyclin H (lane 
11) and CDK7 (lane 14) was readily detected. 
The coimmunoprecipitation results suggested that p36 
promotes stable binding of CDK7 and cyclin H. When 
CDK7- and cyclin H-containing lysates were mixed and 
subjected to gel exclusion chromatography (Figure 5A), 
both proteins migrated near their monomeric positions 
(- 40-50 kDa), but were shifted slightly toward an interme- 
diate position, indicating that CDK7 and cyclin H interact 
to some extent in the absence of ~36. The peaks were 
consistently offset by one fraction, however, suggesting 
unstable complex formation, with significant dissociation 
during chromatography. Addition of p36-HA-containing ly- 
sate caused a dramatic shift in the migration of all three 
proteins, to a position consistent with a molecular weight 
of 175-200 kDa(Figure 5B), and coincident with the appar- 
ent size of authentic CAK purified from HeLa S-100 (see 
Figure 3; data not shown). In addition to the increased 
apparent size, there was precise comigration of all three 
CAK components, indicating stable complex formation. 
Similar results were obtained with highly purified fractions 
of p36-His (- 90% pure), cyclin H (>95% pure), and CDK7 
(- 90% pure), all at final concentrations prior to chroma- 
tography of 1 PM each (data not shown). Thus, p36 is a 
novel CDK7-cyclin H assembly-promoting factor. 
p36 Binding Bypasses the Requirement for T170 
In Vitro and In Vivo 
We previously reported the reconstitution of active CAK 
with CDK7 and cyclin H alone (Fisher and Morgan, 1994). 
CDK7 and cyclin H form a stable complex in vivo when 
coexpressed in Saccharomyces cerevisiae or by transient 
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Figure 5. p36 Promotes CAK Assembly 
(A) CDK7 and cyclin H do not form stable complexes in the absence 
of ~36. Lysates containing CDK7 and cyclin H-His were mixed and 
subjected to Superose 12 gel filtration. Fractions were analyzed by 
immunoblotting with antibodies against CDK7 and cyclin H. In sepa- 
rate runs, monomeric CDK7 peaked rn fraction 26, while monomeric 
cyclin H peaked in fraction 29 (data not shown). Positions of molecular 
weight standard proteins are indicated at top. 
(B) p36 promotes formation of a stable CAK complex. Lysates con- 
taining CDK7, cyclin H-His, and p36-HA were mixed and subjected 
to Superose 12 gel filtration. Fractions were analyzed as in (A); p36- 
HA was detected by immunoblotting with MAb 12CA5. 
transfection in COS cells without p36 overexpression (Ma- 
kelaet al., 1994; F. H. Espinozaand D. 0. M., unpublished 
data). The conserved T170 residue of CDK7 was required 
for its interaction with cyclin H in the yeast interaction 
screen (Makela et al., 1994). These studies suggested the 
existenceof p36-independent pathwaysforCAKassembly 
in both mammalian cells and budding yeast and implicated 
an amino acid residue, T170, known to be phosphorylated 
in vivo (Labbe et al., 1994; Poon et al., 1994) in mediating 
that assembly. 
To test whether formation of a stable three-subunit com- 
plex depended on T170, we performed gel filtration an- 
alysis of two- and three-component mixtures containing 
CDK7-HA bearing a T170A mutation. When the mutant 
CDK7-HA(T170A) was incubated with pure cyclin H prior 
to Superose 12 chromatography (Figure 6A), both sub- 
units shifted to a position intermediate between their 
monomeric forms, again indicating some association. 
However, when asimilarmixturewassubjectedtochroma- 
tography on a different resin, Superdex 75, the two sub- 
units largely separated (data not shown), suggesting that 
the complexes were unstable. When CDK7-HA(T170A) 
was incubated with pure cyclin H and pure p36-His prior to 
chromatography, stable three-subunit complexes formed, 
and they migrated with the same apparent size as did 
wild-type complexes (Figure 6B; compare with Figure 5B). 
Cyclin H appeared to be in excess in this experiment, as 
a significant fraction remained at its monomeric position 
(fraction 29). However, both CDK7-HA(T170A) and p36- 
His shifted to the larger size (fractions 23 and 24). We 
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Figure 6. p36-Mediated CAK Assembly Is Independent of T170 
(A) Interaction of CDK7-HA(T170A) with cyclin H. A lysate containing 
the mutant CDK7 was incubated with pure cyclin H and analyzed by 
Superose 12 gel filtration and immunoblotting with MAb 12CA5 and 
anti-cyclin H antibodies. 
(B) Formation of a trimeric mutant CAK complex. Mutant CDK7 and 
cyclin H were mixed and analyzed as in (A), with the addition of pure 
p36-His. p36-His was detected by immunoblotting with anti-p36 anti- 
bodies. 
(C) p36 bypasses the T170 requirement for active CAK formation. The 
mutant CDK7-HA(T170A) lysate (- 1.2 pg of CDK7) was incubated 
with cyclin H alone (0.7 ng, lanes 1 and 3) or with cyclin H (0.7 ng) 
and p36-His (1.2 ug, lanes 2 and 4). Complexes were immunoprecipi- 
tated with MAb 12CA5 and assayed forcyclin H binding by immunoblot- 
ting (lanes 1 and 2) and for CAK activity by CDK2 phosphorylation 
(lanes 3 and 4). 
(D) Dual mechanisms of CAK assembly in viva. CAK subunits CDK7- 
HA (wild-type or T170A mutant), cyclin H, and p36 were transiently 
expressed in COS cells, in the combinations indicated above each 
lane. CDK7-cyclin H association was assessed by immunoprecipita- 
tion with MAb 12CA5 and immunoblotting with antibodies against 
cyclin H (arrow at left). 
next compared the amounts of cyclin H that coimmuno- 
precipitated with CDK7-HA(T170A) in the absence (Figure 
6C, lane 1) or presence (lane 2) of pure p36-His. Again, 
p36 caused an approximate 5-fold enhancement of 
CDK7-cyclin H association. In fact, cyclin H binding bythe 
mutant CDK7 in the presence of p36 was indistinguishable 
from that of wild-type CDK7 (data not shown). Remarkably, 
the mutant trimeric complex was also as active as the 
wild-type complex in phosphorylating CDK2 (Figure 6C, 
lane 4). Thus, p36 bypassed the requirement for T170 in 




That p36 can also circumvent the T170 requirement in 
vivo was shown by transient expression in COS cells of 
either wild-type or T170A mutant forms of CDK7-HA to- 
gether with cyclin H, in either the presence or the absence 
of p36 (Figure 6D). CDK7-HA-containing complexes were 
immunoprecipitated and analyzed by immunoblotting for 
coprecipitating cyclin H. Wild-type CDK7 bound compara- 
ble amounts of cyclin H in the absence (lane 2) or presence 
(lane 3) of ~36. The T170A mutant, in contrast, showed 
a marked defect in cyclin H binding in the absence of p36 
(lane 4; compare with wild type, lane 2). The defect was 
completely overcome by the coexpression of p36 (lane 5). 
The results with the mutant CDK7 suggest that p36 levels 
are limiting for assembly of trimeric CAK complexes in 
COS cells. Moreover, the lack of a dramatic effect of p36 
overexpression on assembly of wild-type CDK7-cyclin H 
complexes implies the existence of a p36-independent, 
T170-dependent CAK assembly pathway. 
An Alternative CAK Assembly Pathway Requires 
an Activating Kinase 
Mammalian CDK7 is phosphorylated in vivo at two major 
sites: T170 and S164 (P. J. and D. 0. M., unpublished 
data). Because the S164 residue is in the context of a 
perfect CDC2/CDK2 consensus phosphorylation site 
(Labbe et al., 1994; Poon et al., 1994), we tested the ability 
of pure activated CDKP-cyclin A and CDC2-cycl in B com- 
plexes to phosphorylate CDK7 in vitro. Surprisingly, both 
CDKs appeared to phosphorylate CDK7 with astoichiome- 
try exceeding one mole of phosphate per mole of protein; 
tryptic phosphopeptide mapping revealed efficient phos- 
phorylation of both S164 and T170 when CDK7 was incu- 
bated with either CDK2-cyclin A or CDC2-cycl in B (R. P. F. 
and D. 0. M., unpublished data). It is not clear whether 
CDKs phosphorylate T170 directly or stimulate autophos- 
phorylation of Ti 70, perhaps by phosphorylating S164. In 
either case, these results raised the possibility of a poten- 
tial positive feedback loop governing the CDK activation 
cycle (see Discussion); moreover, they allowed us to ex- 
amine directly the effect of T170 phosphorylation on CAK 
assembly in vitro. 
We incubated lysates containing CDK7-HA with pure 
cyclin H in the presence of Mg-ATP, in the absence or 
presence of active CDKP-cyclin A complexes, and then 
subjected the mixtures to gel exclusion chromatography 
(Figure 7A). CDKP-cyclin A treatment of wild-type CDK7 
caused both CDK7 and cyclin H to shift quantitatively to 
an apparent size of -70 kDa (second panel from top, 
fraction 26), indicating the formation of a stable binary 
complex containing the -40 kDa CDK7-HA and the 37 
kDa cyclin H subunits. The shift was dependent on T170, 
as CDK2-cyclin A treatment had no effect on the migration 
of either CDK7 or cyclin H in reactions containing the 
T170A mutant (Figure 7A, bottom). Stabilization of the bi- 
nary CDK7-cyclin H complex by CDKP-cyclin A was ac- 
companied by significant CAK activation, as shown by the 
recovery of active CAK after immunoprecipitation of col- 
umn fractions (data not shown). 
To confirm that CDKP-cyclin A could function as a CAK- 
activating kinase (CAKAK) in vitro, we analyzed its effects 
on CDK7-cyclin H complex formation (Figure 76) and CAK 
activation (Figure 7C) in duplicate immunoprecipitations. 
In the absence of p36or CDK2-cyclin A (lanes l), wild-type 
CDK7-HA bound cyclin H weakly, and a low level of CAK 
activity was recovered in the immunoprecipitate. Treat- 
ment with active CDKP-cyclin A prior to immunoprecipita- 
tion caused a dramatic increase in CDK7-cyclin H associ- 
ation (Figure 78, lane 2) and a lo-fold stimulation of 
recovered CAK activity (Figure 7C, lane 2). Addition of 
pure p36 to the reaction caused a similar stimulation 
of both binding (Figure 7B, lane 3) and activation (Figure 
7C, lane 3) even in the absence of CDK2-cyclin A. When 
both p36 and CDK2-cyclin A were present, still higher 
levels of bound cyclin H (Figure 78, lane 4) and CAK activ- 
ity (Figure 7C, lane 4) were immunoprecipitated; however, 
the effects were less than completely additive (data not 
shown). Mutation of T170 to alanine completely abolished 
the response to CDKP-cyclin A (Figures 78 and 7C; com- 
pare lanes 5 and 6), while the p36-dependent assembly/ 
activation pathway remained intact (Figures 78 and 7C, 
lanes 7). In contrast, mutation of S164 to alanine did not 
prevent CDKP-dependent assembly and activation in the 
absence of p36 (Figures 78 and 7C; compare lanes 9 and 
10). The S164A mutant showed somewhat reduced activ- 
ity compared with the wild-type enzyme (Figure 7C; com- 
pare lanes 2 and lo), raising the possibility that the phos- 
phorylation of S164 also contributes to activation. 
Discussion 
A Novel Structure for a Cyclin-Dependent Kinase 
We have cloned and characterized a novel CAK subunit 
that promotesassemblyof CDK7 and cyclin H and remains 
tightly associated with the CDK-cyclin complex. Thus, the 
basic functional unit of CAK is a unique heterotrimeric 
CDK-cyclin-assembly factor complex. In support of this 
idea are previous studies (Tassan et al., 1994; Makela et 
al., 1994) that show stoichiometric association of CDK7 
with cyclin H and another protein of 36 kDa. The 36 kDa 
protein observed by Tassan et al. (1994) has recently been 
identified as the human homolog of the mouse p36 protein 
identified in the present work and has also been shown 
to promote CDK7-cyclin H assembly in vitro (Tassan et 
al., 1995). 
The involvement of an accessory protein in assembly 
of CDK-cyclin complexes is novel; however, a similar 
mechanism may underly the function of the yeast cell cycle 
regulator Cdc37p. In yeast bearing a temperature- 
sensitive Cdc37p, there is a defect in the assembly of 
Cdc28p-cyclin complexes (Gerber et al., 1995). Compari- 
son of the amino acid sequences of p36 and Cdc37p of 
S. cerevisiae reveals no homology, however. A positive 
factor may also be required for the assembly of mamma- 
lian CDK4 and its partners, the D-type cyclins, into func- 
tional complexes (Kato et al., 1994). It will be of interest 
to know whether p36-like proteins are involved in the as- 
sembly of other CDK-cyclin complexes, or indeed whether 
the function of p36 is strictly limited to the CDK7-cyclin 
H pair. 
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p36 Induces a Conformational Change 
in the CAK Complex 
The CDK7-cyclin H-p36 complex assembled in vitro mi- 
grates in gel exclusion chromatography with an unexpect- 
edly large apparent size of - 200 kDa (Figure 5). In con- 
trast, binary CDK7-cyclin H complexes migrate at -70 
kDa (Figure 7A), as expected for heterodimers of 39 kDa 
and 37 kDa subunits. p36 could cause complex dimeriza- 
tion, producing a holoenzyme with an actual mass of - 220 
kDa. However, we were unable to detect significant multi- 
merization of either CDK7 or p36 when we immunoprecipi- 
tated a mixture of HA-tagged and untagged complexes 
with 12CA.5 antibodies under similar conditions (data not 
shown). Sedimentation anafyses of CAK complexes in 
glycerol gradients also failed to provide evidence for a 
higher order CAK complex; there was no significant differ- 
ence between the sedimentation velocities of two- and 
three-subunit complexes (data not shown). Taken to- 
gether, the results of gel exclusion chromatography and 
glycerol gradient sedimentation suggest a conformational 
change in the enzyme upon p36 addition, favoring its ex- 
clusion from the sizing column matrix, rather than multi- 
merization. 
An Alternative CAK Assembly Pathway and a 
Potential Positive Feedback Loop 
The proposed function of p36 as a CAK assembly factor 
raised a paradox: we previously reconstituted active CAK 
with CDK7 and cyclin H alone (Fisher and Morgan, 1994). 
Figure 7. p36-Independent CAK Assembly 
Mediated by T170 Phosphorylation 
(A) Formation of stable binary CDK7-cyclin H 
complexes. Lysates containing wild-type (top 
two panels) or the T170A mutant (bottom two 
panels) forms of CDK7-HA were incubated 
with pure cyclin H and Mg-ATP, in the absence 
or presence (indicated at far left) of activated 
CDKP-cyclin A complexes. The mixtures were 
analyzed by Superose 12 gel filtration and im- 
munoblotting with anti-cyclin H and MAb 
12CA5 (arrows at left). 
(6) T170 phosphorylation stabilizes the binary 
CAK complex. Lysates containing wild-type 
(lanes l-4), T170A(lanes5-i3), orS164A(lanes 
9 and 10) forms of CDK7-HA (0.6 ng) were 
incubated with pure cyclin H (0.5 ng) and Mg- 
ATP in the absence (odd-numbered lanes) or 
presence (even-numbered lanes) of active 
CDK2-cyclinA(125 ng). Where indicated, pure 
p36-His (0.5 &g) was included in the incuba- 
tion. Complexes were immunoprecipitated 
with MAb 12CA5 and analyzed by immunoblot- 
ting with anti-cyclin H antibodies (arrow at left). 
(C) T170 phosphorylation activates CAK, Con- 
ditions were the same as in (B); duplicate immu- 
noprecipitates were tested for CAK activity, 
measured as the ability to phosphorylate 
CDK2-cyclin A. 
yet stable binding of the two appears to require p36 in 
stoichiometric amounts (Figures 4 and 5). In attempting 
to resolve that paradox, we uncovered an intriguing dual 
mechanism for CAK assembly and activation. Stable bi- 
nary CDK7-cyclin H complexes can form when T170 of 
CDK7 is phosphorylated (Figures 6 and 7). This mode of 
CDK-cyclin stabilization has a precedent: phosphoryla- 
tion of an activating threonine residue by CAK is required 
for the assembly of CDC2 and cyclin A (Desai et al., 1995). 
Are the two CAK assembly pathways (schematized in Fig- 
ure 8) redundant mechanisms for ensuring proper CAK 
assembly, or do they reflect real regulatory complexity? 
There is evidence for the existence of binary CDK7- 
cyclin H complexes in vivo; Xenopus oocyte extracts con- 
tain an - 80 kDa form of CDK7 (Fesquet et al., 1993) that 
is apparently devoid of p36 (J. G. Crump, Ft. P. F., and 
D. 0. M., unpublished data). In mammalian cells, the bulk 
of CDK7 and cyclin H appears to be associated with p36 
(Figures 3A and 3B), although there may be a minor popu- 
lation of p36-free CDK7-cyclin H complexes in the high 
salt nuclear extract (Figure 3A). We were able to purify 
binary CDK7-cyclin H complexes from HeLa cells (Fisher 
and Morgan, 1994), perhaps suggesting that a subpopula- 
tion of dimers exists in mammalian cells; we suspect, how- 
ever, that p36 initially associated with human CAK (see 
Figure 3C, lane 1) was lost during purification (R. P. F. 
and D. 0. M., unpublished data). 
Are there conditions under which T170 cannot be phos- 
phorylated in vivo and CAK assembly is truly dependent 
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Figure 6. Alternative Pathways of CAK Assembly 
We have elucidated two mechanisms for assembling stable, active 
CAK. The transient CDK7-cyclin H complex may be stabilized and 
activated by the assembly factor ~36, forming the ternary CAK complex 
that is the predominant form in mammalian cell extracts. This process 
canoccurin theabsenceofactivatingphosphorylation. In thepresence 
of a CAKAK, the binary CDK7-cyclin H complex may be stabilized in 
the absence of p36 by activating threonine phosphorylation. The ability 
of the CAK target enzymes, the CDKs, to activate CAK in vitro by 
this mechanism may point to the existence of a positive activating 
phosphorylation feedback loop in vivo. 
on p36? A definitive answer must await the identification 
of the CAKAK in vivo and assessments of its levels (and 
access to the CDK7 substrate) throughout the cell cycle. 
However,  the evidence that CDCP and CDKP complexes 
are efficient CAKAKs in vitro (Figure 7; data not shown) 
raises the intriguing possibility that they perform thesame 
function in vivo. In that case, CDK activation could,‘be 
governed by a positive feedback loop in which the taigets’ 
of CAK, the CDKs, are also its activators. To initiate the 
loop, however, active CAK must first form in the absence 
of preexisting active CDKs; p36 could fulfill that require- 
ment by bypassing the T170 phosphorylation step (Figure 
8) and could confer autonomy on the trimeric CAK com- 
plex. This model is highly speculative; measurements of 
CAK activity extracted from cells throughout the cell cycle 
have thus far shown little variation. At the least, the p36- 
independent pathway of CAK activation most likely ex- 
plains the seeming discrepancies between this report and 
our previous results (Fisher and Morgan, 1994). Phosphor- 
ylation of T170 probably occurs in insect cells, producing 
subpopulations of CDK7 that can be activated solely by 
cyclin H addition (data not shown). 
A Novel Function for a RING Finger Protein 
p36 is a novel member of a family of proteins that contain 
the C3HC4 zinc-binding or RING finger domain. Functional 
understanding of the RING finger has lagged behind its 
structural characterization (Barlow et al., 1994). In several 
cases, metal binding has been demonstrated (Lovering et 
al., 1993; von Arnim and Deng, 1993), and disruption of 
the C3HC4 domain has been shown to result in a loss of 
biological activity (Everett, 1988). However,  no physiologi- 
cally relevant nucleic acid-binding or protein-protein in- 
teractions involving the domain have been discerned 
(Freemont, 1993; Schwabe and Klug, 1994), owing to a 
lack of direct assays or known targets of these proteins. 
p36 may be more biochemically tractable. We may now 
ask whether the zinc-binding domain of p36 influences 
CAK assembly or conformation. p36 may contain another 
structure, the coiled coil, with the potential to mediate pro- 
tein-protein interactions (Cohen and Parry, 1990). Inter- 
estingly, a subfamily of RING finger proteins that contain 
central or carboxy-terminal coiled-coil motifs has been de- 
scribed (Kastner et al., 1991; Reddyet al., 1992); however, 
p36 lacks the so-called B box, an additional cysteine- and 
histidine-rich motif that is a hallmark of these proteins 
(Freemont, 1993). 
p36 in the CAK-TFIIH Complex 
Does p36 mediate the entry of CAK into the TFIIH holoen- 
zyme? The novel subunit is present in both TFIIH- 
associated and free forms of CAK (Figure 3). It is therefore 
surprising that a potential budding yeast homolog of p36 
has recently been identified as TFB3, the 38 kDa subunit 
‘of core TFIIH (W. J. Feaver and R. D. Kornberg, personal 
communication). Core TFIIH is devoid of kinase activity 
and is dissociated from the constituent CDK of holoTFIIH, 
Kin28p (Svejstrup et al., 1994, 1995). If p36 and TFB3 are 
analogous proteins, it is tempting to speculate that their 
different behavior in vitro points to a role in recruiting or 
tethering CAK to the TFIIH core. 
Although CAK can be dissociated from TFIIH (Roy et 
al., 1994; Shiekhattar et al., 1995), no reconstitution of 
the holoenzyme has been reported. The instability of the 
CDK7-cyclin H pair, lack of ~36, or both may have pre- 
vented functional reassociation. p36 contains structural 
motifs that may mediate interactions between CAK and 
the TFIIH core. With the definition of the mammalian CAK 
subunit composition, we may turn to the question of how 
the interactions of CAK with TFIIH, and perhaps with other 
proteins, are established, maintained, and regulated. 
Experimental Procedures 
Purification of Murine CAK and Tryptic Peptide Sequencing 
CAK was purified from mouse 3T3 ceils through the HiTrap Cl (Phar- 
macia) stage and transferred to polyvinylidene difluoride (PVDF) as 
previously described (Fisher and Morgan, 1994). We digested a region 
containing both cyclin H and p36 with trypsin. Five peptides were 
resolved by high pressure liquid chromatography and sequenced by 
Edman degradation; only one (HWTFASEEQLAR) had homology to 
human cyclin H. The derivation of the other peptides from a distinct 
protein was confirmed by cloning of a murine cyclin H cDNA. Degener- 
ate primers based on the mouse cyclin H peptide and one from the 
cyclin box region of human cyclin H were used to produce a PCR 
product with which we isolated a nearly full-length cDNA encoding 
mouse cyclin H; the amino acid sequence was 95% identical to that 
of human cyclin H (P. J. and D. 0. M., unpublished data). 
Isolation of a Mouse cDNA Encoding p36 
We obtained a 451 bp PCR product by a nested two-round strategy. 
First, we used the sense primer 5’-GTGGAATTCGAYTAYAAYGAYT- 
TYYT-3’ (Y = T or C), based on peptide 1, and the antisense primer 
5’-GGYTGRTAYTCRTANARNGG3’(R = G or A, N = G, A, T, or C), 
based on peptide 4, with a mouse neuroblastoma cDNA library in 
plasmid pCCM6XL (Lustig et al., 1993) as template. Amplified products 
were used as templates for a second round with the same antisense 
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primer, but with the sense primer5’-GARGARGTNGARGARATHGT-3’ 
(H = A, T, or C), also based on peptide 1. We used the product to 
probe a mouse 3T3 cDNA library in hZAPll (Stratagene). Five positive 
recombinants were confirmed by secondary and tertiary screening. 
We sequenced both strands of one of the larger inserts. 
Construction of Baculoviruses 
A fragment containing the p36 coding region was inserted in transfer 
vector pVLCDKPNHA @ ‘Reilly et al., 1993; Rosenblatt et al., 1993) 
to produce untagged ~36, or in pVLl393His (H. Jones and D. 0. M., 
unpublished data) to produce p36-His. To produce p36-HA, we intro- 
duced an Ncol site at the S’end of the open reading frame by oligonu- 
cleotide-directed mutagenesis (Kunkel, 1965) and cloned the resulting 
Ncol-Ncol fragment in pVLCDK2NHA. 
Purification of Proteins Overexpressed in Insect Cells 
We infected SF9 cells as previously described (Desai et al., 1992). 
For purification of untagged proteins and for production of crude ly- 
sates, cells were lysed in buffer A (IO mM HEPES, 10 mM NaCI, 5 mM 
EDTA, 1 mM dithiothreitol [DTT], 1 mM phenylmethylsulfonylfluoride 
[PMSF], 2 uglml aprotinin, 1 ug/ml leupeptin [pH 7.41). For purification 
of His-tagged proteins, cells were lysed in buffer B (20 mM sodium 
phosphate, 20 mM NaCI, 0.5 mM DTT, 1 mM PMSF, 2 pglml aprotinin, 
1 uglml leupeptin [pH 7.61). The concentrations of sodium phosphate 
and NaCl were then raised to 50 mM and 300 mM, respectively, and 
lysates were clarified by centrifugation. Crude CDK7- or CDK7- 
HA-containing lysates were desalted on PDlO (Pharmacia) columns 
equilibrated in buffer C (25 mM HEPES, 1 mM EDTA, 10% glycerol, 
1 mM EDTA, pH 7.4) plus 150 mM NaCI. 
Lysates containing p36-Hiswere applied to a5 ml column of cobalt- 
iminodiacetic acid-Sepharose 6B (Sigma), equilibrated in buffer D (50 
mM sodium phosphate, 300 mM NaCI, 10% glycerol [pH 7.81). The 
column was washed with buffer D plus 0.5 mM DTT and developed 
with a linear gradient of O-300 mM imidazole in buffer D plus 0.5 mM 
DTT. Fractions containing p36-His were pooled, diluted It-fold with 
buffer C, and applied to a 1 ml HiTrap Q (Pharmacia) column equili- 
brated in buffer C plus 75 mM NaCI. The column was developed with 
a linear gradient of 75-400 mM NaCl in buffer C. p36-His-containing 
fractions were pooled, concentrated in acentricon 30 (Amicon), centri- 
fuged for 30 min at 100,000 x g.” in an airfuge (Beckman), and applied 
to a 25 ml Superose 12 (Pharmacia) column equilibrated in buffer C 
plus 150 mM NaCI. 
Lysates contain ing CDK7 were passed over a - 20 ml diethylamino- 
ethyl (DEAE) Fast Flow (Pharmacia) column equilibrated in buffer C 
plus 50 mM NaCI. CDK7flowed through and was purified by sequential 
chromatographies on HiTrap SP (Pharmacia), Superdex 200 (Phar- 
macia), and ATP-agarose (Sigma). 
Cyclin H was purified by sequential ion exchange chromatography 
on S Sepharose Fast Flow (Pharmacia) and HiTrap Q, followed by 
gel filtration on Superose 12. Active CDK2-cyclin A complexes were 
prepared by mixing lysates containing roughly equal amounts of CDK2 
and cyclin A, adding a fraction of HeLa cell CAK purified through the 
DEAE step (Fisher and Morgan, 1994) and incubating for 30 min at 
room temperature in the presence of 10 mM MgCk and 1 mM ATP. 
The complex was then purified by sequential Mono Q (Pharmacia) 
and ATP-agarose chromatographies and was -80% pure (H. Jones 
and D. 0. M., unpublished data). In CAK activation assays (Figures 
78 and 7C), 125 ng of the complex (final concentration: 25 nM) was 
used to activate 0.6 ug of CDK7 (final concentration: 300 nM). 
Subcellular Fractionation of CAK Complexes 
HeLa cells grown in suspension to mid-log phase were harvested by 
centrifugation and fractionated into a soluble high speed supernatant 
(S-l 00) and a high salt nuclear extract according to published methods 
(Dignam et al., 1983). The nuclear extract was centrifuged for 30 min 
at 100,000 x g=“, and both fractions were subjected to gel filtration 
on a 125 ml Superdex 200 column equilibrated in buffer C plus 100 
mM NaCI. Fractions (1.5 ml) were analyzed by immunoblotting. 
CAK Assays 
Activation of CDKP-cyclin A-associated histone Hl kinase by murine 
CAKfractions was tested as previously described (Fisher and Morgan, 
1994). Reconstitution of CAK in vitro was performed as described 
(Fisher and Morgan, 1994), except that where indicated, reactions 
contained p36-HA and untagged CDK7. Mixtures of desalted lysates, 
orofthe pureCAKsubunits, were incubatedfor30min at room temper- 
ature in HEPES-buffered saline (HBS; 10 mM HEPES, 150 mM NaCl 
[pH 7.41) plus 1 mM DTT. Complexes were immunoprecipitated with 
monoclonal antibody(MAb) 12CA5 (BAbCO) bound to Protein A-Seph- 
arose (Sigma). lmmunoprecipitates were washed three timeswith HBS 
plus 0.1% Triton X-100 and twice with HBS plus 1 mM DTT and were 
assayed for the ability to phosphorylate CDKP (1 ug per assay), as 
previously described (Fisher and Morgan, 1994). 
CAK Assembly Assays 
To measure binding of cyclin H to CDK7-HA, immunoprecipitateswere 
prepared as described above and analyzed by immunoblotting with 
anti-cyclin H antibodies. To assess pairwise binding of CDK7 and 
cyclin H to p36-HA, we incubated crude lysate containing - 1 ug of 
p36-HA with 1 pg of pure CDK7, 1 ug of pure cyclin H, or both, prior 
to immunoprecipitation with MAb 12CA5. Duplicate blots were probed 
with antibodies to CDK7 and cyclin H. 
Mixtures of crude lysates containing - 40 ug of CDK7 (1.8 mg of 
total protein) and -40 ug of cyclin H-His (400 ug of total protein), 
with and without - 40 pg of p36-HA (1.8 mg of total protein), were 
incubated at room temperature for 30 min in a volume of 200 1.11, centri- 
fuged for 30 min at 100,000 x ga. in an airfuge, and applied to a 25 
ml Superose 12 column equilibrated in buffer C plus 150 mM NaCI. 
Fractions (0.5 ml) were analyzed by immunoblotting with antibodies 
against CDK7, cyclin H, and the HA epitope. CDK7-HA(T170A)- 
containing complexes were formed by incubating a desalted lysate 
containing -10 ug of the mutant CDK7 with pure cyclin H (10 ug) 
with or without pure p36-His (10 ng) and analyzed by Superose 12 
chromatography and immunoblotting with antibodies against cyclin H, 
~36, and the HA epitope. To assess the effect of CDKP-cyclin A on 
binary CDK7-cyclih f-l complex formation, we incubated lysates con- 
taining - 10 ug of CDK7-HA (wild-type or T170A) with 10 ug of pure 
cyclin H, with or without active CDK2-cyclin A complex (2.5 Kg), in 
the presence of :lO mM MgCI, and 1 mM ATP for 30 min at room 
temperature. Samples were then airfuged and subjected to Superose 
12 chromatography. Fractions were analyzed by immunoblotting with 
anti-cyclin H and MAb 12CA5 antibodies. 
COS Cell Transfections 
Transfection vectors encoding wild-type and T170A mutant forms of 
CDK7-HA, cyclin H, and p36 were constructed in vector pcDLSRa296 
(Takebe et al., 1988). Transient transfections of COS cells were per- 
formed by the DEAE-dextran method, essentially as described (Gu 
et al., 1990) using 7.5 pg of DNA (containing 2.5 ug of each CAK 
subunit expression construct or nonrecombinant vector) per 10 cm 
dish. Cells were lysed 48 hr after transfection. MAb 12CA5 immunopre- 
cipitates were isolated from 200 ug of total protein and analyzed by 
immunoblotting with anti-cyclin H antibodies. In addition, 25 ug of 
each lysate was analyzed directly by immunoblotting with MAb 12CA5, 
anti-cyclin H, and anti-p36 antibodies. Expression levels of the three 
polypeptides varied by at most 1.5-fold between transfections (data 
not shown). 
Immunologic Methods 
Rabbit polyclonal antisera were raised against a GST-CDK7 fusion 
protein and purified by affinity for His-tagged C,DK7 immobilized on 
nitrocellulose, according to published methods (Smith and Fisher, 
1984). Antibodies to cyclin H were raised against cyclin H-His purified 
from bacteria (Fisher and Morgan, 1994) and affinity-purified with the 
same protein coupled to Affigel 10 (Bio-Rad). Antibodies were raised 
to p36-His purified through the HiTrap 0 step and affinity-purifed with 
the same protein coupled to Affigel 15 (Bio-Rad) to prepare an immu- 
noaffinity resin. Antibodies affinity-purified on p36-His immunoblots 
were used to probe Western blots. Antibodies to p62 were the gift of 
Drs. R. Shiekhattar, R. Drapkin, and D. Reinberg. 
Anti-cyclin H or anti*36 antibodies were covalently coupled to Pro- 
tein A-Sepharose (Harlow and Lane, 1988). Fractions were passed 
over the affinity column three times. The column was washed with 
HBS plus 0.1% Triton X-100 and eluted with 100 mM triethylamine 
Cdl 
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(pH 11.5) into tubes containing 1110 vol of 1 M  Tris-HCI (pH 7.5). 
Fractions were analyzed by immunoblotting for CDK7, cyclin H, ~36, 
and ~62. 
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